open access

Vol 67, No 2 (2017)
Review paper
Published online: 2017-10-16
Get Citation

Hypoxia in prostate cancer

Justyna Danielska1, Jolanta Łuniewska-Bury, Łukasz Kuncman, Jacek Fijuth
·
Nowotwory. Journal of Oncology 2017;67(2):132-136.
Affiliations
  1. Department of Radiation Therapy, University Department of Oncology, Medical University of Łódź, Poland

open access

Vol 67, No 2 (2017)
Review article
Published online: 2017-10-16

Abstract

Most human solid tumours contain areas which are less oxygenated than normal tissues. Hypoxia increases resistance to radiotherapy, surgery and chemotherapy, and directly alters the function of tumour cells, stimulating them to de-differentiate and to release angiogenic factors with a view to increasing the blood and oxygen supply. Tumour hypoxia promotes malignant progression and metastasis formation. HIF-1 is a heterodimeric transcription factor composed of regulated HIF-1α and constitutively expressed HIF-1β. Tumour-associated activation of HIF-1α seems to be primarily, however the result of adaptation to oxygen shortage. The presence of the HIF-1α subunit overexpression has been confirmed in many tumours, in prostate cancer, among others; the role it plays in its progression is yet to be explained. Numerous studies strongly emphasize the importance of evaluating the status of the HIF-1α transcription factor in predicting the clinical and biochemical recurrence of prostate cancer and its resistance to castration.

Abstract

Most human solid tumours contain areas which are less oxygenated than normal tissues. Hypoxia increases resistance to radiotherapy, surgery and chemotherapy, and directly alters the function of tumour cells, stimulating them to de-differentiate and to release angiogenic factors with a view to increasing the blood and oxygen supply. Tumour hypoxia promotes malignant progression and metastasis formation. HIF-1 is a heterodimeric transcription factor composed of regulated HIF-1α and constitutively expressed HIF-1β. Tumour-associated activation of HIF-1α seems to be primarily, however the result of adaptation to oxygen shortage. The presence of the HIF-1α subunit overexpression has been confirmed in many tumours, in prostate cancer, among others; the role it plays in its progression is yet to be explained. Numerous studies strongly emphasize the importance of evaluating the status of the HIF-1α transcription factor in predicting the clinical and biochemical recurrence of prostate cancer and its resistance to castration.

Get Citation

Keywords

hypoxia, prostate cancer, hypoxia-inducible factor 1

About this article
Title

Hypoxia in prostate cancer

Journal

Nowotwory. Journal of Oncology

Issue

Vol 67, No 2 (2017)

Article type

Review paper

Pages

132-136

Published online

2017-10-16

Page views

645

Article views/downloads

807

DOI

10.5603/NJO.2017.0021

Bibliographic record

Nowotwory. Journal of Oncology 2017;67(2):132-136.

Keywords

hypoxia
prostate cancer
hypoxia-inducible factor 1

Authors

Justyna Danielska
Jolanta Łuniewska-Bury
Łukasz Kuncman
Jacek Fijuth

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl